ARCHIVES

Zytiga and Prednisone Extends Overall Survival in mCRPC Trial

This article is from The Cancer Letter archive.

Vol. 37 No. 10 | October 31, 2014

Download PDF Visit The Full Archive

Related Articles

NCI’s Justification For 1981 Budget

June 8, 1979

DCT Board Approves Concepts For Acoustic Microscopy, Taxol Development, AIDS R&D

June 15, 1990

Cancer Biomarker Research “Piecemeal and Unorganized,” IOM Report Finds.

April 6, 2007

Intramural Clinical Research Could Lose “Critical Mass” – Chabner

November 11, 1994

Funding Opportunities: NCI Meeting Scheduled For Applicants Of RFA On Pediatric Consortium

February 27, 1998

In Brief: Home Health Care Cost Effectiveness Data Sought Through Community Based Programs

May 20, 1977